Novel frameworks for trifluoromethyl ketone and phosphonate TSA inhibitors of type II PLA2

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 11, 1997, Pages 1421-1426

  Garigipati, Ravi S ^a   Seibel, George ^a   Mayer, Ruth J ^a   Bolognese, Brian ^a   McCord, Mark ^a   Marshall, Lisa A ^a   Adams, Jerry L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; REACTION ANALYSIS;

EID: 0030960441     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00246-1     Document Type: Article

References (26)

1. 2 research in the recent years are discussed in the following reviews, (a) Mayer, R. J.; Marshall L. A. FASEB J. 1993, 7, 339.
2. (b) Connolly, S.; Robinson, D. H. Drug News Perspect. 1993, 6, 584.
3. (c). Glaser, K.B.; Mobilio, D.; Chang, J. Y.; Senko, N. TIPS 1993, 14, 92.
4. (d) Mayer, R. J.; Marshall L. A. Exp. Opin. Invest. Drugs 1996, 5, 535.
5. Kudo, I.; Murakami, M.; Kara, S.; Inoue, K. Bio. et Biop. Acta 1993, 117, 217.
6. Bomalaski, J. S.; Clark, M. A. Arthritis and Rheumatism 1993, 36 (2), 190.
7. Marshall, L. A.; Roshak, A. Biochem. Cell Biol. 1993, 71, 331.
8. (a) Marjolein, M. G. M.; Thunnissen, E. A. B.; Kor, H. K.; Drenth, J.; Dijkstra, B. W.; Kuipers O. P.; Dijkman, R.; de Haas, G. H.; Verheij, H. M. Nature (London) 1990, 347, 689.
9. (b) Scott, D. L.; White, S. P.; Zbyszek, O.; Yuan, W.; Gelb, M. H.; Sigler, P. B. Science 1990, 250, 1541.
10. Scott, D. L.; White, S. P.; Browning, J. L.; Rosa, J. J.; Gelb, M. H.; Sigler, P. B. Science 1991, 254, 1007.
11. Clark, J. D.; Schievella, A. R.; Nelefski, E. A.; Lin, L. L. J. Lipid Mediat. Cell Signal 1995, 12, 83.
12. Hulkower, K. I.; Hope, W. C.; Chen, T.; Anderson, C. M.; Coffey, J. W.; Morgan, D. W. Biochem. Biophys. Res. Commun. 1992, 184, 712-718.
13. Le Mahieu, R. A.; Carson, M.; Han, R.-J.; Madison, V. S.; Hope, W. C.; Hendricson, H. S. J. Med. Chem. 1993, 36, 3029.
14. Schevitz, R. W.; Bach, D. G; Carlson, D. G.; Chirgadze, N. K.; Clawson, D. K.; Dillard, R. D.; Draheim, S. E.; Hartley, L. W.; Jones, N. D.; Mihelich, E. D.; Olkowski, J. L.; Snyder, D. W.; Sommers, C.; Wery, J.-P. Nature Structural Biology 1995, 2, 458.
15. Begue, J.-P.; Mesureur, D. Synthesis 1989, 309.
16. Begue, J.-P.; Delpon, D. B. Tetrahedron 1991, 47, 3207.
17. 50 of greater than 50 μM.
18. 1H NMR indicated that compound 2 underwent gradual decomposition by an aldol type process.
19. 2 acyl hydrolysis using a membrane assay (0.1 ng enzyme and tritiated-arachidonk acid E. coli). Inhibitors 10 and 18 showed no cell based toxicity at 30 μM as determined by trypan blue exclusion.
20. Marshall, L. A.; Hall, R. H.; Winkler, J. D.; Badger, A.; Bolognese, B.; Roshak, A.; Flamberg, P. L.; Sung, C. M.; Chabot-Fleteher, M.; Adams, J. L.; Mayer, R. J. J Pham Exper Ther. 1995, 274, 1254.
21. Gelb, M. H. J. Am. Chem. Soc. 1986, 108, 3146.
22. Holt, D. A.; Erb, J. M. Tetrahedron Lett. 1989, 40, 5393.
23. (a) Marshall, L. A.; Bolognese, B.; Yuan, W.; Gelb, M. Agents and Actions 1991, 34, 106.
24. (b) Marshall, L. A.; Bolognese, B.; Winkler, J. D.; Roshak, A. J. Biol. Chem. 1997, 272, 759
25. 21
26. Ferrin, T. E.; Huang, C. C.; Jarvis, L. E.; Langridge, R. J. Mol. Graphics 1988, 6, 13. MidasPlus program supplied by the Computer Graphics Laboratory, University of California, San Francisco (supported by NIHRR-01081).